USPTO trademark

ANAKA PHARMA

AllowedUSPTOWord and designClass 5Class 42

"ANAKA PHARMA" is a word and design mark owned by Anaka Pharmaceuticals, Inc., filed at the USPTO on April 7, 2025. It has been allowed and covers classes 5 and 42.

Get this data via the API

Data current as of July 21, 2026Official USPTO record

As filed with the USPTO

Status: Allowed; Since July 20, 2026
Filed: April 7, 2025
Registered: Not yet
Expires: Not recorded
Application no.: 99123382
Registration no.: Not yet
Office: USPTO; United States Patent and Trademark Office
Mark type: Word and design; 2 classes

Ownership

Who owns ANAKA PHARMA

The owner and representative on file with the office.

Owner

Anaka Pharmaceuticals, Inc.

Lexington, United States

Representative

Laura K. Johnson

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Goods and services

What the mark covers

The products and services ANAKA PHARMA is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Small molecule therapeutic pharmaceuticals for the treatment of neurodevelopmental disorders, namely, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, and Down syndrome
42Class 42 · Computer and Scientific Services
Pharmaceutical research and development for neurodevelopment disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

July 21, 2026Notice of approval of extension request e-mailed
July 20, 2026Sou extension 1 granted
July 20, 2026Sou extension 1 filed
July 20, 2026Sou teas extension received
January 20, 2026Noa e-mailed - sou required from applicant
November 25, 2025Official gazette publication confirmation e-mailed
November 25, 2025Published for opposition
November 19, 2025Notification of notice of publication e-mailed
October 23, 2025Approved for pub - principal register
October 22, 2025Teas/email correspondence entered

10 earlier steps on the official record.

FAQ

About ANAKA PHARMA

Who owns the trademark "ANAKA PHARMA"?

The USPTO trademark "ANAKA PHARMA" (application 99123382) is owned by Anaka Pharmaceuticals, Inc.

What is the status of "ANAKA PHARMA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ANAKA PHARMA and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2aa5-6949-704e-bcf8-fa15c018ce93
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2aa5-6949-704e-bcf8-fa15c018ce93",
  "object": "trademark",
  "mark_text": "ANAKA PHARMA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99123382",
  "filing_date": "2025-04-07",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Anaka Pharmaceuticals, Inc.",
      "entity_id": null
    }
  ]
}